Showing results (371-380 of 509) with videos related to

Sort By:
Pageof 51
The Journal of Rheumatology|March 1, 1976
Pseudotumor of temporomandibular joint: destructive calcium pyrophosphate dihydrate arthropathyK P Pritzker, H Phillips, S C Luk, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1986
Platelet function studies in myeloproliferative disordersG Pfliegler, Z Boda, M Udvardy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2018
Training in communication of oncology clinicians: a position paper based on the third consensus meeting among European experts in 2018F Stiefel, A Kiss, P Salmon, et al.
Cancer Detection and Prevention|January 1, 1997
Downregulation of major histocompatibility complex class I expression and susceptibility to natural killer cells in cells transformed with the oncogenic adenovirus 12 are regulated by different E1A domainsI Huvent, C Cousin, A Kiss, et al.
Minerva Chirurgica|April 15, 1990
[Endoscopic resolutions of volvulus of the sigmoid colon]B M Marino, G W Drago, R Rossi, et al.
Orvosi Hetilap|May 15, 1994
[Eosinophilic leukemia: a rare form of Philadelphia chromosome negative chronic myeloid leukemia?]B Telek, J Kiss, F Tóth, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 1999
Comparison of the toxicity of fluconazole and other azole antifungal drugs to murine and human granulocyte-macrophage progenitor cells in vitroI Benko, F Hernádi, A Megyeri, et al.
Gastroenterology|April 1, 1987
Intravenous cisapride accelerates delayed gastric emptying and increases antral contraction amplitude in patients with primary anorexia nervosaG Stacher, H Bergmann, S Wiesnagrotzki, et al.
Current Oncology (Toronto, Ont.)|July 17, 2020
Willingness of women with early estrogen receptor-positive breast cancer to take adjuvant CDK4/6 inhibitorsN J Lipton, J Jesin, E Warner, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 2, 2021
Synthesis of dihydrotestosterone derivatives modified in the A-ring with (hetero)arylidene, pyrazolo[1,5-a]pyrimidine and triazolo[1,5-a]pyrimidine moieties and their targeting of the androgen receptor in prostate cancerMárton A Kiss, Miroslav Peřina, Václav Bazgier, et al.
Pageof 51